Conditions: Rosacea
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 205
Healthy volunteers: no

Brief summary:
This study is designed to:

1. assess the signs and symptoms of rosacea, including erythema, without treatment and during treatment with Mirvaso® gel
2. further characterize lifestyle impact and patient satisfaction with Mirvaso® treatment
3. gain a better understanding of the real-world use of Mirvaso® on the pattern and management of facial erythema of rosacea.

Detailed description:

Arms:
arm 1: Brimonidine topical gel, 0.33%

Interventions: intervention 1: Brimonidine
Intervention descriptions: intervention 1: None

Protocol document: